Albert David Ltd. Surges to 52-Week High, Outperforms Sector and Sensex in Past Year

Sep 03 2024 10:05 AM IST
share
Share Via
Albert David Ltd., a microcap pharmaceutical company, has reached a 52-week and all-time high stock price of Rs. 1752.95 on September 3rd, 2024. With a 'Hold' recommendation from MarketsMojo and outperforming its sector, the company has shown strong potential and growth in the past year, making it a promising investment in the pharmaceutical industry.
Albert David Ltd. is a microcap pharmaceutical company that has recently seen a surge in its stock price. On September 3rd, 2024, the company's stock reached a 52-week high of Rs. 1752.95, which is also an all-time high for the company. This significant increase in stock price has caught the attention of investors and market analysts.

According to MarketsMOJO, a leading stock market analysis platform, the current recommendation for Albert David Ltd. is 'Hold'. This means that investors should hold onto their current positions in the company's stock and not make any new investments at this time.

In terms of performance, Albert David Ltd. has outperformed its sector by 0.39% and has been on a consecutive gain streak for the past 4 days. In this period, the stock has seen a 11.37% increase in returns. The stock also touched an intraday high of Rs. 1752.95, showing a 2.67% increase.

Furthermore, Albert David Ltd. is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend in the company's stock price.

In the past year, Albert David Ltd. has shown a remarkable performance with a 117.14% increase in its stock price, while the Sensex has only seen a 26.09% increase. This shows the company's strong potential and growth in the pharmaceutical industry.

In conclusion, Albert David Ltd. has seen a significant increase in its stock price, reaching a 52-week and all-time high. With a 'Hold' recommendation from MarketsMOJO and a strong performance in the past year, the company shows promise for future growth in the microcap pharmaceutical industry.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News